Pre-order Enquiry
Request Free Sample
Global Cephalosporin Sales Market Report 2021
SKU ID : QYR-17364557 | Publishing Date : 09-Feb-2021 | No. of pages : 142
Request Sample
Request Customization
Check Discounts
Cephalosporin is an antibiotic medication commonly prescribed to treat several different types of infections.
The classification of Cephalosporin includes First Generation, Second Generation, Third Generation, Fourth Generation and the proportion of Third Generation in 2016 is about 37.2%, and the proportion is in increasing trend from 2012 to 2016. China is the largest supplier of Cephalosporin, with a production market share nearly 43% in 2016. India is the second largest supplier of Cephalosporin, enjoying production market share nearly 22.3% in 2016. Market competition is intense. Union Chempharma, NCPC, Qilu Antibiotics, Lupin Pharmaceuticals, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Market Analysis and Insights: Global Cephalosporin Market
The global Cephalosporin market was valued at US$ 3988.7 in 2020 and will reach US$ 4465.6 million by the end of 2027, growing at a CAGR of 1.9% during 2022-2027.
Global Cephalosporin Scope and Market Size
The global Cephalosporin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cephalosporin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
First Generation Cephalosporin
Second Generation Cephalosporin
Third Generation Cephalosporin
Fourth Generation Cephalosporin
Segment by Application
Oral
Injection
The Cephalosporin market is analysed and market size information is provided by regions (countries). Segment by Application, the Cephalosporin market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Union Chempharma
NCPC
Qilu Antibiotics
Lupin Pharmaceuticals
Hospira
Dhanuka Laboratories
Fukang
Dongying Pharmaceutical
Alkem
SALUBRIS
LIVZON
Hetero Drugs
CSPC
TEVA
Orchid Pharma
Taj Pharmaceuticals
Covalent Laboratories
United Laboratories
Aurobindo
Wockhardt
LKPC
HPGC
Huafangpharm
The classification of Cephalosporin includes First Generation, Second Generation, Third Generation, Fourth Generation and the proportion of Third Generation in 2016 is about 37.2%, and the proportion is in increasing trend from 2012 to 2016. China is the largest supplier of Cephalosporin, with a production market share nearly 43% in 2016. India is the second largest supplier of Cephalosporin, enjoying production market share nearly 22.3% in 2016. Market competition is intense. Union Chempharma, NCPC, Qilu Antibiotics, Lupin Pharmaceuticals, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Market Analysis and Insights: Global Cephalosporin Market
The global Cephalosporin market was valued at US$ 3988.7 in 2020 and will reach US$ 4465.6 million by the end of 2027, growing at a CAGR of 1.9% during 2022-2027.
Global Cephalosporin Scope and Market Size
The global Cephalosporin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cephalosporin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
First Generation Cephalosporin
Second Generation Cephalosporin
Third Generation Cephalosporin
Fourth Generation Cephalosporin
Segment by Application
Oral
Injection
The Cephalosporin market is analysed and market size information is provided by regions (countries). Segment by Application, the Cephalosporin market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Union Chempharma
NCPC
Qilu Antibiotics
Lupin Pharmaceuticals
Hospira
Dhanuka Laboratories
Fukang
Dongying Pharmaceutical
Alkem
SALUBRIS
LIVZON
Hetero Drugs
CSPC
TEVA
Orchid Pharma
Taj Pharmaceuticals
Covalent Laboratories
United Laboratories
Aurobindo
Wockhardt
LKPC
HPGC
Huafangpharm
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
